Page last updated: 2024-08-23

pirfenidone and Albuminuria

pirfenidone has been researched along with Albuminuria in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dunn, SR; McGowan, TA; Okada, S; RamachandraRao, SP; Ravasi, T; Sharma, K; Shaw, MA; Toh, I; Zhu, Y	1
Declèves, AE; Sharma, K	1
Cho, M; Donohue, M; Dunn, SR; Falkner, B; Fervenza, FC; Francos, B; Ix, JH; Kopp, JB; Mathew, AV; McGowan, TA; Pflueger, A; Ramachandrarao, S; Sharma, K; Sharma, S; Xu, R	1

Reviews

1 review(s) available for pirfenidone and Albuminuria

Article	Year
New pharmacological treatments for improving renal outcomes in diabetes. Nature reviews. Nephrology, 2010, Volume: 6, Issue:6 Topics: Albuminuria; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Biomarkers; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Protein Kinase C; Pyridones; Renin; Transforming Growth Factor beta	2010

Article

Year

New pharmacological treatments for improving renal outcomes in diabetes.

Nature reviews. Nephrology, 2010, Volume: 6, Issue:6

Topics: Albuminuria; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Biomarkers; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Protein Kinase C; Pyridones; Renin; Transforming Growth Factor beta

2010

Trials

1 trial(s) available for pirfenidone and Albuminuria

Article	Year
Pirfenidone for diabetic nephropathy. Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:6 Topics: Adult; Aged; Albuminuria; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Creatinine; Diabetic Nephropathies; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrosis; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Pyridones; Treatment Outcome	2011

Article

Year

Pirfenidone for diabetic nephropathy.

Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:6

Topics: Adult; Aged; Albuminuria; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Creatinine; Diabetic Nephropathies; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrosis; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Pyridones; Treatment Outcome

2011

Other Studies

1 other study(ies) available for pirfenidone and Albuminuria

Article	Year
Pirfenidone is renoprotective in diabetic kidney disease. Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:8 Topics: Albuminuria; Animals; Antineoplastic Agents; Cell Line; Diabetic Nephropathies; Eukaryotic Initiation Factor-4E; Extracellular Matrix Proteins; Gene Expression; Humans; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; Phosphorylation; Proteomics; Pyridones; Reactive Oxygen Species; RNA Processing, Post-Transcriptional; Signal Transduction; Transforming Growth Factor beta1	2009

Article

Year

Pirfenidone is renoprotective in diabetic kidney disease.

Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:8

Topics: Albuminuria; Animals; Antineoplastic Agents; Cell Line; Diabetic Nephropathies; Eukaryotic Initiation Factor-4E; Extracellular Matrix Proteins; Gene Expression; Humans; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; Phosphorylation; Proteomics; Pyridones; Reactive Oxygen Species; RNA Processing, Post-Transcriptional; Signal Transduction; Transforming Growth Factor beta1

2009